AksharChem (India) Limited Overview
AksharChem (India) Limited is a Gujarat-based, promoter-controlled manufacturer of colour chemicals and inorganic specialty fillers. Its legacy franchise is Vinyl Sulphone (VS) — a key intermediate for reactive dyes — where the company describes itself as one of India's leading exporters, supplemented by H-Acid, reactive dyes, and copper phthalocyanine (CPC) Green pigment (Pigment Green 7, brand "Asaflow") inherited from sister company Asahi Songwon Colors in 2014. Since 2022 it has diversified into precipitated silica (brand "Aksil") at Dahej for tyre, rubber, agrochemical and animal-feed customers, scaling capacity to 18,000 TPA in June 2025. The company exports to more than 30 countries but has re-emphasised the domestic market. After three weak years (FY2023–FY2026) marked by Chinese price competition, a May-2024 fire at its VS plant, rising debt and thin margins, Q1 FY2027 delivered a sharp earnings inflection (PAT ₹15.2 Cr on ~₹141 Cr revenue), which has re-rated the stock roughly 2.5x from its March-2026 lows.
Company's own description (FY2024-25 Annual Report, MD&A)
In its most recent available Management Discussion & Analysis (36th Annual Report, FY2024-25), the company characterises itself as one of India's leading chemical manufacturers with an export focus spanning over 30 countries, while noting it has redirected attention to the domestic market as a future growth driver. It divides its offering into organic chemicals (Vinyl Sulphone, H-Acid, CPC Green) serving textile, ink, plastic and paint applications, and inorganic chemicals (precipitated silica) serving tyre, rubber, agrochemical and animal-feed industries. Manufacturing is located at Chhatral/Indrad (Mehsana) and Dahej. The MD&A states that FY2024-25 production volume was 19,224 MT with blended capacity utilisation of 82%, and that the company has "successfully penetrated" the precipitated silica requirements of major Indian tyre and rubber makers, with expansion options under evaluation across conventional precipitated silica, micro-pearl silica and highly dispersible silica (HDS). Brand names cited: Asaflow (Pigment Green 7) and Aksil (precipitated silica).
Independent characterisation
AksharChem is best understood as a two-engine, B2B commodity-to-specialty chemical producer:
-
Colour chemicals engine (Indrad, Mehsana): A mid-sized, non-integrated producer of naphthalene/benzene-derived dye intermediates (VS, H-Acid), a small reactive-dye line (Reactive Blue 21, Reactive Black 5 per third-party descriptions), and a CPC Green pigment line. Economics are dictated by the spread between intermediate prices and raw materials (acetanilide, chlorosulphonic acid, naphthalene derivatives, copper phthalocyanine crude), and above all by Chinese supply discipline and Chinese environmental enforcement. This is a classic cyclical "China-plus-one" business: margins expand when Chinese capacity is shut or constrained and collapse when Chinese exports flood the market.
-
Inorganic fillers engine (Dahej): Precipitated silica, a reinforcing filler used predominantly in tyres (especially "green tyre" formulations where HDS grades reduce rolling resistance), footwear and technical rubber, and as a carrier/anti-caking agent in agrochemicals and animal feed. This business is more domestically anchored, tied to Indian tyre-capacity expansion and import substitution, and structurally less exposed to Chinese dye-intermediate cycles — although it competes with imports and with multinational producers.
Business model and revenue model. Revenue is almost entirely product sales (manufacturing for spot and contract supply), with no meaningful service, subscription or licensing income. The company sells to dye manufacturers (VS, H-Acid), textile processors/traders (reactive dyes), paint, ink and plastics compounders (Pigment Green 7), and tyre/rubber/agro/feed processors (silica). Ancillary operating income includes export incentives and scrap; FY2026 also included insurance-claim receipts booked as exceptional items.
Value-chain position. Mid-stream. AksharChem buys basic and intermediate chemicals (it is not backward-integrated into sulphuric acid, chlor-alkali or benzene derivatives, unlike Bodal Chemicals) and sells intermediates and colorants into further-downstream formulators. In silica it converts sodium silicate and sulphuric acid into finished filler grades.
Customer types. Industrial manufacturers and global chemical majors (the company states it supplies VS to "the world's leading chemical companies"); Indian tyre majors in silica. Customer concentration is not publicly disclosed in sources reviewed.
End-markets. Textiles (cotton reactive dyeing), paints & coatings, printing inks, plastics masterbatch, tyres and technical rubber, agrochemicals, animal feed.
Strategy
Stated strategic themes (FY2024-25 MD&A and company website)
The company has not held an investor day, and no formal medium-term strategy document was identified. Its stated themes, paraphrased, are:
-
Domestic market as a growth driver alongside a 30+ country export base.
-
Precipitated silica scale-up, including evaluation of conventional, micro-pearl and highly dispersible grades for the tyre industry.
-
Operational excellence: website "Key Highlights" cite ~80% capacity utilisation through better planning and plant uptime, packaging automation, long-term raw-material supply contracts, shop-floor training and acquisition of new overseas customers.
-
Environmental positioning: the company describes itself as among the most environment-friendly chemical companies; pollution-treatment expenditure is tracked as a KPI (Screener lists "Annual Pollution Treatment Expenses as % of Revenue").
Strategic initiatives announced in the last 24 months
| Initiative | Date | Description | Status |
|---|---|---|---|
| Dahej precipitated silica expansion | Commissioned 24-Jun-2025 | +6,000 TPA to 18,000 TPA; aimed at tyre and rubber customers; broader size range and product selection | Completed |
| VS plant reconstruction after fire | May–Dec 2024 | Rebuild of dry zone; regulatory trial revocation from GPCB | Completed; insurance partly settled |
| Captive solar — Banaskantha | Operating 12-Nov-2025 | 5.19 MWp DC ground-mounted, reduces grid power cost at Indrad | Completed |
| Captive solar — Bharuch | Operating 24-Apr-2026 | 2.4 MWp DC for Dahej silica plant | Completed |
| Executive bench refresh | 21-May-2026 | WTD appointment | Completed |
| HDS / micro-pearl silica | Under evaluation (FY25 MD&A) | Higher-value tyre-tread silica | No capex announcement verified |
Guidance and targets
Management guidance: Not publicly disclosed. No revenue, margin or capex guidance was found in filings, and no earnings-call transcripts exist. Cost programmes with targets: None quantified publicly. Sustainability targets: No quantified emissions or renewable-share targets disclosed; the ~7.6 MWp of captive solar is the tangible commitment.
Products & Services
Pricing is market-determined and not disclosed by the company. Launch years are given where verifiable.
Dye Intermediates Division (Indrad)
| Product | Description & key specs | Target customer | Launch / status | Notes |
|---|---|---|---|---|
| Vinyl Sulphone Ester (VS, "Acetanilide base"), para-base | 4-β-sulphatoethylsulphonyl aniline; the reactive anchor in vinyl-sulphone reactive dyes (e.g., Reactive Black 5) | Reactive dye manufacturers in India, China, Europe, SE Asia | Core product since founding (1989/1990s) | Company claims to be one of India's leading VS exporters and among the fastest-growing VS makers |
| Ortho Anisidine Vinyl Sulphone (OAVS) | VS derivative based on o-anisidine; used for specific reactive dye shades | Reactive dye makers | Listed in portfolio | Per Wright Research product description |
| Sulpho Para Vinyl Sulphone (Sulpho VS) | Sulphonated VS variant for bi-functional reactive dyes | Reactive dye makers | Listed in portfolio | Per Wright Research |
| H-Acid | 1-amino-8-naphthol-3,6-disulphonic acid; key coupling component for azo reactive and direct dyes | Dye manufacturers | Added in FY2017-18 capex cycle | 1,200 MTPA; utilisation 96% (Tijori). Prices firmed through Q3-2025–Q1-2026 per industry trackers |
Dyes Division (Indrad)
| Product | Description | Target customer | Status |
|---|---|---|---|
| Reactive Blue 21 | Copper-phthalocyanine-based turquoise reactive dye | Cotton textile dyers/printers | Listed in portfolio |
| Reactive Black 5 | Bis-vinyl-sulphone reactive black; the single largest-volume reactive dye globally | Cotton textile dyers | Listed in portfolio |
Pigments Division (Indrad; brand "Asaflow")
| Product | Description | Target customer | Status |
|---|---|---|---|
| Pigment Green 7 (CPC Green, C.I. 74260) | Chlorinated copper phthalocyanine green; high light/heat/chemical fastness | Paints, printing inks, plastics masterbatch | Transferred from Asahi Songwon via demerger effective 1-Apr-2014; 2,400 MTPA |
| Pigment Violet 23 | Carbazole dioxazine violet | Inks, coatings, plastics | Listed in third-party portfolio descriptions |
Inorganic Division (Dahej; brand "Aksil")
| Product family | Description | Target customer | Status |
|---|---|---|---|
| Conventional precipitated silica | Amorphous synthetic silica (SiO₂) produced by acidification of sodium silicate; reinforcing filler | Tyres (non-tread compounds), footwear, technical rubber | Commercial since 2022 |
| Precipitated silica for agro/feed | Carrier, flow and anti-caking agent | Agrochemical formulators; animal-feed premix makers | Commercial |
| Micro-pearl silica (MP) | Granulated, low-dust grade for better dispersion | Tyre and rubber compounders | Under consideration per FY25 MD&A |
| Highly Dispersible Silica (HDS) | Premium grade for "green tyre" treads (lower rolling resistance, better wet grip) | Tyre OEMs | Under consideration per FY25 MD&A; not yet confirmed commercial |
Captive energy assets (non-revenue)
| Asset | Capacity | Location | Commissioned |
|---|---|---|---|
| Ground-mounted solar | 5.19 MWp DC / 3.85 MW AC | Makdala, Deodar, Banaskantha | 12-Nov-2025 |
| Ground-mounted solar | 2.4 MWp DC / 1.75 MW AC | Sardarpura, Jhagadiya, Bharuch (supplies Dahej) | 24-Apr-2026 |
Financial Narrative
Basis: Standalone, Ind AS, INR M, fiscal years ending 31 March. Primary dataset: S&P Global Market Intelligence (via StockAnalysis.com, updated 12-Aug-2026), cross-checked against exchange filings (FY2024 and FY2026 newspaper extracts; FY2026 iXBRL). EBITDA is derived from the S&P EV/EBITDA ratio and matches Screener's "operating profit" within rounding. Margins and coverage ratios are analyst calculations.
Income statement: notes and sources
Notes: FY2022 EPS is ₹19.50 per TipRanks and ₹19.81 per Screener (weighted-share-count difference around the Dec-2021 buyback). FY2026 exceptional item of ₹169.61 lakh (₹17.0 M) is the fire-insurance receipt recognised in Q3 FY26; FY2026 PBT before exceptional items was ₹-61.4 M (₹-613.92 lakh per the company's newspaper extract). DPS for FY2022–FY2024 is derived from dividends paid in the following year's cash-flow statement (₹3.9–4.0 M on 8.03 M shares ≈ ₹0.50); FY2025 dividend of ₹60.25 lakh total (₹0.75/share) per the FY25 Directors' Report; FY2026 ₹0.50 (5%) per the 21-May-2026 outcome.
Margin profile (%)
Revenue CAGR: FY2021–FY2026 (5-year, FY2021 revenue ₹2,460 M per TipRanks): +8.6% (Screener independently reports 8.61% five-year sales growth). FY2022–FY2026 (4-year): -0.5%. FY2024–FY2026 (2-year): +11.0%.
Commentary — income statement. The five-year arc is a textbook commodity cycle compounded by company-specific shocks. FY2022 was a peak: post-COVID textile restocking and Chinese supply constraints pushed revenue up 54% and EBITDA to ₹316 M. FY2023 and FY2024 saw a double compression — revenue fell 21% cumulatively as Chinese VS and H-Acid exports normalised and realisations slumped, while EBITDA collapsed to just ₹14 M in FY2024 (0.5% margin), producing a ₹187 M net loss inflated by a ₹31 M tax charge despite a pre-tax loss (likely deferred-tax write-downs). FY2025 recovered (+14.6% revenue, EBITDA ₹247 M) even though the VS plant was shut for over seven months after the 2-May-2024 fire — indicating the silica business and H-Acid were carrying the company. FY2026 revenue grew 7.6% to a record ₹3,724 M, but EBITDA fell to ₹169 M as depreciation (Dahej expansion, solar assets) and interest (debt up 63%) rose, quarterly volatility was high (Q3 FY26 loss of ₹46 M), and the year closed with a ₹4.4 M net loss only after a ₹40 M tax credit and ₹17 M of insurance income. The headline FY2026 Q4 PAT of ₹48.4 M on a pre-tax loss of ₹10.0 M underscores that reported earnings were tax-driven, not operating-driven.
Q1 FY2027 inflection. The June-2026 quarter is the first unambiguous operating turnaround: revenue ~₹1,409 M (+45.3% YoY), PBT ₹159.5 M (vs ₹10.3 M), PAT ₹152.1 M, EPS ₹18.94, with no exceptional items (ScanX; Bajaj Broking). Net margin was ~10.8%. Single-quarter PAT exceeded the cumulative PAT of FY2023–FY2026 combined. Investor commentary attributes this to an H-Acid/VS price upcycle linked to Chinese supply developments and ~25% YoY firmer silica pricing (ValuePickr forum post).
Quarterly trajectory: notes and sources
Sources: Q1FY26 total income ₹969.99 M (multibagg/TipRanks ₹969.62 M); Q2FY26 sales ₹893.0 M (Geojit/Capitaline); Q3FY26 net loss ₹461.56 lakh (NSE iXBRL), revenue derived from net-margin data (Bajaj Broking, -5.74%) — approximate; Q4FY26 revenue ₹1,057.9 M and PAT ₹48.35 M (company extract; Groww); Q1FY27 per ScanX/Bajaj Broking. Interest per Arthneeti quarterly data (₹ Cr ×10). Q2/Q3 FY26 EPS are analyst calculations on 8.03 M shares.
Balance sheet
Source: S&P via StockAnalysis (balance sheet updated 12-Aug-2026). Cash discrepancy: one StockAnalysis view shows FY2026 cash of ₹17.42 M, while the detailed view shows ₹1.53 M for 31-Mar-2026 and ₹17.42 M for 30-Jun-2026; the latter attribution is used. Screener shows borrowings of ₹108 Cr (FY26), ₹67 Cr (FY25), ₹52 Cr (FY24), consistent with the table.
Commentary — balance sheet. The balance sheet has shifted from conservatively financed to moderately stretched. Net debt more than quadrupled from ₹245 M (FY2023) to ₹1,083 M (FY2026), funded primarily through short-term working-capital borrowings (₹805 M of the ₹1,085 M total), while long-term debt stayed modest. The driver was a ₹970 M cumulative capex programme over FY2024–FY2026 (Dahej silica expansion, solar plants, VS plant reconstruction) that was not covered by operating cash flow. Working capital turned negative (₹-22 M) and the current ratio fell below 1.0x (0.99x) at FY2026 — a liquidity watch-point given the company holds virtually no cash. Equity has been flat at ~₹2.6 bn for three years (book value ~₹326/share), so leverage remains moderate in absolute terms (net debt/equity 0.41x), but the maturity profile is short. There is no goodwill; intangibles are immaterial. Asset backing is tangible (land ₹271 M, buildings ₹866 M, plant & machinery ₹2,947 M gross per S&P), which supports lender comfort.
Cash flow
Buyback FY2022 = 1,69,491 shares × ₹590 = ₹100.0 M (tender offer, letter of offer dated 30-Nov-2021); S&P groups it within "other financing activities" (₹-143.5 M including buyback tax and lease/interest items).
Commentary — cash flow. AksharChem has generated positive free cash flow in only one of the last five years (FY2023, when a ₹239 M working-capital release coincided with low capex). Cumulative FCF over FY2022–FY2026 is approximately ₹-587 M, matched by ~₹937 M of net new borrowing — i.e., the company has borrowed to fund both capex and working capital. OCF is highly volatile because receivables and inventories swing with commodity prices: FY2026 OCF of only ₹17 M reflects a ₹148 M increase in receivables (DSO rose to ~61 days) as Q4 revenue spiked. Dividend outflows are token (₹4–6 M). The FY2023 outlier shows that, in a downturn, working-capital release can temporarily mask poor earnings.
Return, leverage and efficiency ratios
Sources: ROE/ROA/ROIC/ROCE, current/quick ratios, D/E, net debt/EBITDA, asset and inventory turnover per S&P via StockAnalysis; coverage ratios and working-capital days are analyst calculations from the tables above (days computed on revenue for consistency, because the FY2026 COGS reclassification distorts COGS-based measures). Tijori Finance reports a cash conversion cycle of 24.7 days (inventory 56.8, receivable 46.4, payable 81.5 days, COGS-based, period not specified) — a materially different methodology; both are noted.
Commentary — ratios. Returns on capital have been sub-economic for four straight years: ROIC peaked at 5.6% (FY2022) and averaged roughly -0.2% over FY2023–FY2026, far below any reasonable cost of capital for a cyclical Indian micro-cap (12–14%). The pattern reflects a capital base (₹2.6 bn equity plus ₹1.1 bn debt) that has grown with capex while EBITDA has not. The trailing picture changes dramatically if Q1 FY2027 is sustained: annualising Q1 PAT of ₹152 M would imply ROE above 20%. S&P's "current" ROIC of 4.42% (TTM to Jun-2026) already shows the improvement. Interest coverage is the key financial risk metric — at 0.1x EBIT/interest in FY2026 the company was dependent on lender forbearance in a downturn; Q1 FY2027 coverage is comfortably above 5x.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Margins & Growth (%)
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Chemicals (single reportable segment) revenue INR Mn | 3,020 | 3,463 | 3,724 |
YoY growth % | -9.8 | 14.6 | 7.6 |
% of total revenue | 100 | 100 | 100 |
Product Lines
| Product line | Installed capacity (MTPA) | Location | Latest disclosed utilisation | Source |
|---|---|---|---|---|
Vinyl Sulphone (VS, incl. OAVS/Sulpho VS variants) | 7,800 | Indrad, Mehsana | 79% | Tijori Finance |
H-Acid | 1,200 | Indrad, Mehsana | 96% | Tijori Finance |
Dye intermediates combined | 9,000 | Indrad | — | Tijori Finance |
CPC Green (Pigment Green 7; Violet 23 listed) | 2,400 | Indrad | 78% | Tijori Finance |
Precipitated silica (Aksil) | 12,000 → 18,000 (from 24-Jun-2025) | Dahej | not disclosed post-expansion | Equitybulls; Tijori |
Total (pre-expansion) | 23,400 | — | 82% blended (FY2025) | IIFL; FY25 MD&A |
Total (post-expansion, analyst calc.) | 29,400 | — | — | Analyst calculation |
“—” = not publicly disclosed.
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue INR Mn | 3,803 | 3,347 | 3,020 | 3,463 | 3,724 |
Revenue growth % | 54.3 | -12.0 | -9.8 | 14.6 | 7.6 |
Gross profit INR Mn (S&P basis) | 1,471 | 1,138 | 1,182 | 1,454 | 969 |
EBITDA INR Mn | 316 | 153 | 14 | 247 | 169 |
Depreciation & amortisation INR Mn | 121 | 128 | 137 | 139 | 164 |
Operating income (EBIT) INR Mn | 195 | 26 | -123 | 108 | 5 |
Interest expense INR Mn | 16 | 27 | 33 | 46 | 68 |
Exceptional / unusual items INR Mn | 5 | 0 | 0 | -40 | 17 |
Pre-tax income INR Mn | 179 | -5 | -156 | 58 | -44 |
Income tax expense INR Mn | 20 | 4 | 31 | 11 | -40 |
Net income INR Mn | 159 | -9 | -187 | 48 | -4 |
EPS basic INR | 19.50 | -1.17 | -23.25 | 5.94 | -0.55 |
EPS diluted INR | 19.50 | -1.17 | -23.25 | 5.94 | -0.55 |
Dividend per share INR | 0.50 | 0.50 | 0.50 | 0.75 | 0.50 |
Margin Analysis (%) — Gross margin %
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin % (S&P basis; FY26 not comparable) | 38.7 | 34.0 | 39.1 | 42.0 | 26.0 |
EBITDA margin % | 8.3 | 4.6 | 0.5 | 7.1 | 4.5 |
Operating (EBIT) margin % | 5.1 | 0.8 | -4.1 | 3.1 | 0.1 |
Pre-tax margin % | 4.7 | -0.1 | -5.2 | 1.7 | -1.2 |
Net margin % | 4.2 | -0.3 | -6.2 | 1.4 | -0.1 |
Financial Analysis
| Metric | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|
Revenue INR Mn | 970 | 893 | 805 | 1,058 | 1,409 |
Net profit INR Mn | 7.1 | -13.7 | -46.2 | 48.4 | 152.1 |
EPS INR | 0.89 | -1.70 | -5.75 | 6.02 | 18.94 |
Interest INR Mn | 14.3 | 13.8 | 18.5 | 21.5 | — |
“—” = not publicly disclosed.
Financial Analysis (Annual)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets INR Mn | 4,060 | 3,652 | 3,805 | 4,153 | 4,516 |
Cash & equivalents INR Mn | 1.4 | 1.5 | 1.6 | 1.4 | 1.5 |
Short-term debt incl. current LTD INR Mn | 278 | 81 | 344 | 535 | 906 |
Long-term debt INR Mn | 225 | 165 | 175 | 133 | 179 |
Total debt INR Mn | 503 | 246 | 518 | 668 | 1,085 |
Net debt INR Mn | 501 | 245 | 517 | 666 | 1,083 |
Shareholders' equity INR Mn | 2,797 | 2,784 | 2,592 | 2,637 | 2,615 |
Goodwill & intangibles INR Mn | 4.0 | 3.0 | 2.2 | 1.5 | 0.9 |
Net PP&E INR Mn | 2,468 | 2,426 | 2,457 | 2,760 | 2,954 |
Capital work-in-progress INR Mn | 160 | 174 | 112 | 446 | 84 |
Receivables INR Mn | 549 | 374 | 484 | 462 | 646 |
Inventory INR Mn | 725 | 593 | 649 | 705 | 730 |
Trade payables INR Mn | 501 | 383 | 435 | 574 | 539 |
Working capital INR Mn | 669 | 649 | 483 | 190 | -22 |
Book value per share INR | 348.2 | 346.5 | 322.7 | 328.3 | 325.6 |
Financial Analysis (FY2022–FY2026)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow INR Mn | 43 | 379 | -66 | 348 | 17 |
Change in working capital INR Mn | -232 | 239 | -129 | 101 | -169 |
Capital expenditure INR Mn | 249 | 89 | 168 | 442 | 360 |
Free cash flow INR Mn | -206 | 290 | -234 | -94 | -343 |
Dividends paid INR Mn | 29.5 | 3.9 | 4.0 | 4.0 | 6.0 |
Share buybacks INR Mn | 100 | 0 | 0 | 0 | 0 |
Net debt issued (repaid) INR Mn | 355 | -256 | 272 | 149 | 417 |
Cash interest paid INR Mn | 20.6 | 33.6 | 37.3 | 52.6 | 68.2 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE % | 5.70 | -0.34 | -6.95 | 1.82 | -0.17 |
ROA % | 3.20 | 0.42 | -2.06 | 1.70 | 0.07 |
ROIC % | 5.56 | 0.81 | -4.00 | 2.77 | 0.14 |
ROCE % | 6.10 | 0.80 | -4.10 | 3.60 | 0.20 |
Current ratio x | 1.78 | 2.25 | 1.59 | 1.17 | 0.99 |
Quick ratio x | 0.64 | 0.72 | 0.59 | 0.40 | 0.42 |
Debt to equity x | 0.18 | 0.09 | 0.20 | 0.25 | 0.42 |
Net debt to EBITDA x | 1.59 | 1.60 | 36.41 | 2.69 | 6.40 |
Interest coverage EBIT to interest x | 11.9 | 0.9 | -3.7 | 2.4 | 0.1 |
EBITDA to interest x | 19.4 | 5.6 | 0.4 | 5.4 | 2.5 |
Asset turnover x | 1.00 | 0.87 | 0.81 | 0.87 | 0.86 |
Inventory turnover x | 3.58 | 3.35 | 2.96 | 2.97 | 3.18 |
Receivable days (revenue basis) | 51 | 39 | 57 | 43 | 61 |
Inventory days (revenue basis) | 70 | 65 | 78 | 74 | 72 |
Payable days (revenue basis) | 48 | 42 | 53 | 61 | 53 |
Cash conversion cycle days (revenue basis) | 72 | 62 | 83 | 57 | 80 |
Valuation Snapshot
| Metric | Value | As of | Source |
|---|---|---|---|
Last close | ₹419.90 (BSE) / ₹418 | 16/17-Oct-2026 | StockAnalysis; Kotak Neo |
1-month return | +8.2% | 16-Oct-2026 | MarketsMojo |
6-month return | +113.0% | 16-Oct-2026 | MarketsMojo |
1-year return | +55.1% | 16-Oct-2026 | MarketsMojo |
3-year return | ~+32.6% | 13-Sep-2026 | Anand Rathi |
52-week high / low | ₹472 / ₹141.30 | 16-Oct-2026 | Kotak Neo |
Fiscal year-end closing prices | FY22 ₹345.26; FY23 ₹203.60; FY24 ₹250.63; FY25 ₹213.06; FY26 ₹144.73 | — | S&P via StockAnalysis |
Capital Markets
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Closing share price INR | 345.26 | 203.60 | 250.63 | 213.06 | 144.73 |
Market capitalisation INR Mn | 2,797 | 1,647 | 2,024 | 1,718 | 1,164 |
Enterprise value INR Mn | 2,932 | 1,911 | 2,375 | 2,368 | 1,891 |
Valuation Multiples
| Multiple | AksharChem (current, 15-Oct-2026) | AksharChem FY2026 year-end | Peer reference (Fyers peer table, ~Oct-2026) |
|---|---|---|---|
P/E (TTM) | 23.8x | n.m. (loss) | Bodal 35.8x; Bhageria 22.7x; Shree Pushkar 22.1x; Ultramarine 13.6x; Asahi Songwon 13.2x; Sudarshan 133.9x |
EV/EBITDA | 13.3x | 11.2x | Bodal 11.0x; Kiri 4.4x; Vidhi 12.5x |
EV/Sales | 1.07x | 0.51x | — |
P/B | 1.29x | 0.45x | — |
Dividend yield | 0.12% | 0.34% | — |
Capital Markets — Dividend per share INR
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share INR | 0.50 | 0.50 | 0.50 | 0.75 | 0.50 |
Dividend as % of face value | 5.0 | 5.0 | 5.0 | 7.5 | 5.0 |
Analyst Conclusions
Management guidance
None publicly issued. The company does not provide quantitative guidance or hold earnings calls.
Consensus growth expectations
None available (no published estimates).
Bull case (grounded in data)
-
Cycle has turned decisively. Q1 FY27 revenue grew 45% YoY and PAT reached ₹152 M with no exceptional items — evidence that H-Acid/VS spreads and silica pricing have moved structurally higher with Chinese supply constraints. If even half of Q1's profitability persists, FY2027 EPS could exceed ₹40, putting the stock at ~10x forward earnings.
-
Capex cycle complete, cash harvest ahead. FY2024–FY2026 capex of ~₹970 M (silica expansion, plant rebuild, solar) is now in the asset base; with capex normalising toward maintenance levels and EBITDA rising, FCF could turn strongly positive, deleveraging the ₹1,083 M net debt within roughly two years.
-
Asset value floor. Book value of ~₹326/share and a tangible, recently-expanded plant base mean the stock trades at only ~1.3x book despite a potential return to double-digit ROE; replacement cost of an 18,000 TPA silica plant plus 9,000 MTPA of intermediates capacity likely exceeds the current ~₹444 Cr EV.
Bear case (grounded in data)
-
Cyclical peak, not new normal. In FY2022 the company also posted strong earnings, followed by two years in which revenue fell 21% and EBITDA collapsed to ₹14 M. Chinese supply disruptions historically reverse within quarters; the stock's 190% rise from the March-2026 low may be capitalising peak earnings.
-
Weak balance-sheet resilience. With near-zero cash, a 0.99x current ratio, ~84% of debt short-dated and FY2026 EBIT/interest of 0.1x, a renewed downturn would quickly pressure liquidity and could force equity dilution or asset sales.
-
Structural disadvantages persist. Sub-scale, non-integrated, near-zero R&D, single-site concentration, and environmental-regulatory exposure (the 2024 GPCB episode) cap through-cycle returns — ROIC has averaged below 1% over four years, and governance is concentrated in the founding family.
Key catalysts and monitorables (next 12 months)
| Catalyst | Timing | What to watch |
|---|---|---|
| Q2 FY27 results | 19-Oct-2026 | Sustainability of Q1 margins (EBITDA margin ≥12%?), working-capital build, debt level |
| Q3 FY27 results | ~Jan/Feb-2027 | Seasonal textile demand; Chinese supply normalisation |
| FY27 results & dividend | ~May-2027 | Full-year ROE, dividend uplift, debt reduction |
| Chinese H-Acid/VS supply | Continuous | Restart of Chinese capacity, feedstock (naphthalene/coal tar) availability, Chinese environmental inspections |
| Silica pricing and HDS decision | Continuous | Any capex announcement for micro-pearl/HDS silica; tyre OEM approvals |
| Exchange surveillance status | Continuous | Exit from BE/trade-to-trade series and ASM would improve liquidity |
| Insurance claim final settlement | Unspecified | Additional exceptional income |
| Regulatory | Continuous | GPCB consent renewals; any environmental notices in the Mehsana cluster |
Concluding analyst verdict
AksharChem is a small, promoter-controlled Gujarat chemical manufacturer whose investment case has abruptly shifted from "deep value with no catalyst" to "cyclical earnings inflection priced for continuation." For four years the company destroyed value on any return-on-capital measure: revenue was roughly flat from FY2022 to FY2026 at about ₹370–380 Cr, EBITDA margins oscillated between 0.5% and 8%, free cash flow was negative in four of five years, and net debt quadrupled to ₹108 Cr as management completed a silica expansion, rebuilt a fire-damaged VS plant and installed captive solar. The stock reflected this, bottoming near 0.45x book in March 2026.
The June-2026 quarter changed the narrative. PAT of ₹15.2 Cr — more than the previous four fiscal years combined — on 45% revenue growth, with no exceptional items, shows how much operating leverage sits in a fully built, well-utilised asset base when dye-intermediate spreads widen. The market has responded, re-rating the shares to ~₹420 (≈1.3x book, ≈24x trailing earnings, ≈13x trailing EV/EBITDA).
Our assessment is that the improvement is real but its durability is unproven. The earnings driver — tighter Chinese H-Acid/VS supply and firmer silica prices — is exogenous and historically mean-reverting, while the company's structural handicaps (scale, lack of integration, negligible R&D, short-dated debt, concentrated governance, single-site risk) are unchanged. The silica business is the genuine long-term differentiator and deserves monitoring for any move into higher-value HDS grades.
On balance, AksharChem merits a neutral, catalyst-dependent stance: the Q2 FY27 print on 19-Oct-2026 is pivotal. Two consecutive quarters of double-digit EBITDA margins with visible debt reduction would justify further upside toward a sustained mid-teens ROE valuation; a reversion toward FY2026-type margins would leave the current price exposed to a sharp de-rating, amplified by low float and trade-to-trade trading.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / dates | Background | Total compensation (INR Mn, latest available) | Source |
|---|---|---|---|---|---|
Mrs. Paru M. Jaykrishna | Founder, Chairperson & Managing Director | Since 1989 (~36 years); reappointed for 1-Apr-2026 to 31-Mar-2029 | Law graduate; bachelor's degrees in Philosophy and Sanskrit, master's in English Literature; first woman elected President of the Gujarat Chamber of Commerce & Industry; former director, Tourism Corporation of Gujarat; also founder-CMD of Asahi Songwon Colors Ltd | 6.00 | Simply Wall St; Asahi Songwon corporate info; ScanX |
Mr. Munjal M. Jaykrishna | Joint Managing Director & CEO | Joint MD since 2009; CEO since 14-Feb-2018 (previously CFO); age ~55 | Promoter family; reappointed at 36th/37th AGM cycle | 9.13 | Simply Wall St; 2009 Annual Report |
Mr. Devalkumar Indrabal Suthar (DIN 11511925) | Whole-Time Director (Executive) | 21-May-2026 to 20-May-2029; shareholder approval sought by postal ballot (e-voting closed 30-Jun-2026) | Background not publicly detailed in sources reviewed | — | ScanX |
Mr. Ashok Barot | Executive Director | ~6 years; resignation noted by board 21-May-2026 | — | 1.73 | Simply Wall St; ScanX |
Mr. Amit Soni | Chief Financial Officer | Appointed within the last ~1–2 years | — | 2.98 | Simply Wall St |
Mr. Mehul Naliyadhara | Company Secretary & Compliance Officer | ~1.3+ years (signatory to filings since 2024) | — | 0.15 (partial year) | Simply Wall St; NSE filings |
Mr. Maheshkumar Patel | Vice President, Operations & Projects | — | — | 3.26 | Simply Wall St |
Mr. Dakshesh Patel | General Manager, Marketing | — | — | — | Simply Wall St |
Mr. Rajesh Samal | General Manager (Works) | Resigned effective 31-Oct-2025 | — | — | ScanX |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
25-Jul-2025 | Board approves reappointment of Paru M. Jaykrishna as CMD for FY2027–FY2029 | Continuity of founder control |
31-Oct-2025 | GM (Works) Rajesh Samal resigns | Plant-level leadership change shortly after VS plant restart |
21-May-2026 | Executive Director Ashok Barot resigns; Devalkumar Suthar appointed WTD | Refresh of executive board bench |
22-Sep-2026 | 37th AGM approves reappointment of Jaykrishna family directors retiring by rotation | — |
Major Shareholders
| Holder category | Stake % | Source |
|---|---|---|
Promoter & promoter group (Jaykrishna family and entities) | 62.70 | IndMoney; Anand Rathi |
Foreign institutional investors | 0.00 | Anand Rathi |
Domestic institutional investors | 0.06 | Anand Rathi |
Retail and other public | ~37.24 | IndMoney; Kotak Neo |
Competitive Landscape
Competitors by Segment
| Product line | Named competitors | Notes |
|---|---|---|
Vinyl Sulphone | Bodal Chemicals (6,000 MTPA new VS plant commissioned 2023 at SPS), Kiri Industries, Shree Pushkar Chemicals & Fertilisers, Bhageria Industries, multiple Chinese producers (Zhejiang/Jiangsu cluster), unlisted Gujarat producers | VS is fragmented; China sets price |
H-Acid | Bodal Chemicals, Kiri Industries, Atul Ltd, Chinese producers | Prices highly sensitive to Chinese naphthalene-chain disruptions |
Reactive dyes | Bodal Chemicals, Kiri Industries, Atul Ltd, Colourtex (unlisted), Archroma/Huntsman-type MNCs, Chinese majors (Zhejiang Longsheng, Runtu) | AksharChem is a marginal player |
CPC Green / phthalocyanine pigments | Asahi Songwon Colors (sister; CPC Blue), Sudarshan Chemical Industries, Ultramarine & Pigments, Meghmani-group pigment businesses, Chinese and DIC/Sun Chemical | Pigment Green 7 is a specialised niche |
Precipitated silica | Madhu Silica (unlisted), Tata Chemicals (HDS silica), Evonik, Solvay/Syensqo, PPG, imports from China/SE Asia | Tyre OEM qualification is a barrier |
Peer Comparison FY2026
| Company | Revenue FY2026 (INR Cr) | Revenue growth FY2026 % | Net profit FY2026 (INR Cr) | Net margin % | EBITDA margin % | R&D % of revenue | Market cap (INR Cr) | Source |
|---|---|---|---|---|---|---|---|---|
AksharChem (India) | 372.4 | 7.6 | -0.4 | -0.1 | 4.5 | ~0.07 (FY25) | ~337 | Filings; S&P |
Bodal Chemicals | 2,013.2 | 16 | 47.0 | 2.3 | 10.3 | — | ~2,457–2,542 | Indian Chemical News (company release 21-May-2026); Tijori; Fyers |
Kiri Industries | — | — | ~5,567 (annual PAT per Fyers; includes one-off DyStar-related gain — not comparable) | — | — | — | ~3,654 | Fyers peer table |
Sudarshan Chemical Industries | — | — | ~22 (annual PAT per Fyers, post-Heubach acquisition) | — | — | — | ~9,699 | Fyers peer table |
Asahi Songwon Colors | — | — | ~18 | — | — | — | ~459 | Fyers peer table |
Recent Developments
Not identified in the period: layoffs, litigation outcomes, guidance revisions (no guidance issued), regulatory penalties.



